In summary, COX-2 promotes carcinogenesis and cancer progression through participating in promoting cell proliferation, inhibiting cell apoptosis, enhancing angiogenesis, promoting cancer stem cell formation, and facilitating immune response shift in tumor microenvironment, COX-2 is deemed to be a promising molecular target for CRC treatment. Here, PTGS2 is linked to cancer.